Tekmira Officially Becomes Arbutus Biopharma

Loading...
Loading...
VANCOUVER, British Columbia and DOYLESTOWN, Pa., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation
ABUS
today announced finalization of its corporate name change from Tekmira Pharmaceuticals Corporation
TKMR
. Arbutus Biopharma ("Arbutus") is an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). Arbutus will begin trading under the new ticker symbol ABUS on the NASDAQ today. The company has also received a new CUSIP number (03879J100) for its common stock.
See full press release
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...